Literature DB >> 2893207

Immune thrombocytopenia caused by flavone-8-acetic acid.

H P Davis, E S Newlands, T Allain, U Hegde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893207     DOI： 10.1016/s0140-6736(88)91201-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro.

Authors:  G G Chabot; M C Bissery; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

Authors:  D J Kerr; T Maughan; E Newlands; G Rustin; N M Bleehen; C Lewis; S B Kaye
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

3.  Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.

Authors:  M B Jameson; P I Thompson; B C Baguley; B D Evans; V J Harvey; D J Porter; M R McCrystal; M Small; K Bellenger; L Gumbrell; G W Halbert; P Kestell
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.